Eczema Topicals
dc.contributor.author | Hirabayashi, Katie |
dc.contributor.other | Children's Hospital of Philadelphia |
dc.date.accessioned | 2025-05-05T13:55:08Z |
dc.date.created | 2024-05-03 |
dc.description | This concept set was developed by a data scientist (KH) for a study led by CHOP clinicians Dr. Jonathan Spergel and Dr. Stan Gabryszewski, which investigates dupilumab use and autoimmune diseases in patients with asthma and atopic dermatitis. The codeset was used to identify a cohort of patients with moderate-to-severe atopic disease, including patients who used moderate-to-severe eczema topicals. The codeset is designed for use with the PEDSnet data model and includes a "severity" column indicating the drug severity (mild, moderate or severe) and a "drug" column indicating one of 28 drugs. |
dc.description.abstract | Concept set intended to identify patients who use topical drugs to treat eczema, for the purpose of defining a study cohort of patients with moderate-to-severe atopic disease. |
dc.identifier.uri | https://pedsnet.org/metadata/handle/20.500.14642/1015 |
dc.language.iso | en-US |
dc.provenance | This concept set was developed for the "Effect of Dupilumab on Onset of Type 1 Disease" study (Incidence of Autoimmune Diseases in Children with Atopy Treated with Dupilumab) to define a cohort of patients with moderate-to-severe atopic disease, including patients with use of moderate-to-severe eczema topicals. |
dc.publisher | PEDSnet |
dc.relation.uri | https://github.com/PEDSnet/dupilumab_t1/blob/main/functions/codeset_generation.R#L548-L1157 |
dc.rights | a CC-BY Attribution 4.0 license. |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
dc.subject | PEDSnet Data Model |
dc.subject | No Formal Review |
dc.subject | Cohort Definition |
dc.subject | Semantic Branded Drug Form |
dc.subject | Semantic Branded Drug Group |
dc.subject | Semantic Branded Drug |
dc.subject | Ingredient |
dc.subject | Semantic Branded Drug Component |
dc.subject | Semantic Clinical Drug |
dc.subject | Semantic Clinical Drug Form |
dc.subject | Semantic Clinical Drug Group |
dc.subject | Semantic Clinical Drug Component |
dc.subject.mesh | Corticosteroid |
dc.subject.mesh | Receptor Agonist |
dc.subject.mesh | Hormone |
dc.subject.mesh | Steroid |
dc.subject.other | RxNorm |
dc.subject.other | RxNorm Extension |
dc.title | Eczema Topicals |
dspace.entity.type | ConceptSet |
local.admin.note | pedsnet_dcc_v53 |
local.quality.status | Needs Refinement |
local.subject.flat | PEDSnet Data Model |
local.subject.flat | No Formal Review |
local.subject.flat | Cohort Definition |
local.subject.flat | Semantic Branded Drug Form |
local.subject.flat | Semantic Branded Drug Group |
local.subject.flat | Semantic Branded Drug |
local.subject.flat | Ingredient |
local.subject.flat | Semantic Branded Drug Component |
local.subject.flat | Semantic Clinical Drug |
local.subject.flat | Semantic Clinical Drug Form |
local.subject.flat | Semantic Clinical Drug Group |
local.subject.flat | Semantic Clinical Drug Component |
relation.isDocumentationOfConceptSet.latestForDiscovery | 7156b9cb-99cf-430f-acc6-040fe7398373 |
relation.isStudyOfConceptSet | 923eec9d-2cca-497f-9d68-d47643c5654d |
relation.isStudyOfConceptSet.latestForDiscovery | 923eec9d-2cca-497f-9d68-d47643c5654d |
Files
Original bundle
1 - 1 of 1